1-7 of 7
D. Irwin
Close
Sort by
Journal Articles

Updated Survival Analyses after Prolonged Follow-Up of the Phase 2, Multicenter CREST Study of Bortezomib in Relapsed or Refractory Multiple Myeloma.

Sundar Jagannath, Bart Barlogie, James R. Berenson, David Siegel, D. Irwin, Paul Richardson, Ruben Niesvizky, Raymond Alexanian, Steven Limentani, Melissa Alsina, Dixie-Lee Esseltine, Kenneth C. Anderson
Journal: Blood
Blood (2007) 110 (11): 2717.
https://doi.org/10.1182/blood.V110.11.2717.2717
Published: 2007
Journal Articles

Relationship between Quality of Response to Bortezomib (btz) and Clinical Benefit in Multiple Myeloma (MM) in the APEX and SUMMIT Studies.

Ruben Niesvizky, P.G. Richardson, P. Sonneveld, M.W. Schuster, M. Coleman, D. Irwin, E.A. Stadtmauer, T. Facon, J. Harousseau, A. Boral, K.C. Anderson
Journal: Blood
Blood (2006) 108 (11): 3529.
https://doi.org/10.1182/blood.V108.11.3529.3529
Published: 2006
Journal Articles

Hematologic Profiles in the Phase 3 APEX Trial.

Sagar Lonial, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 3474.
https://doi.org/10.1182/blood.V106.11.3474.3474
Published: 2005
Journal Articles

Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 2547.
https://doi.org/10.1182/blood.V106.11.2547.2547
Published: 2005
Journal Articles

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

J.F. San Miguel, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 366.
https://doi.org/10.1182/blood.V106.11.366.366
Published: 2005
Journal Articles

Bortezomib Therapy Alone and in Combination with Dexamethasone for Patients with Previously Untreated Multiple Myeloma.

Sundar Jagannath, B. Durie, J. Wolf, E. Camacho, D. Irwin, J. Lutzky, M. McKinley, E. Gabayan, A. Mazumder, J. Crowley, R. Vescio, D. Schenkein
Journal: Blood
Blood (2005) 106 (11): 783.
https://doi.org/10.1182/blood.V106.11.783.783
Published: 2005
Journal Articles

Bortezomib Demonstrates Superior Efficacy to High-Dose Dexamethasone in Relapsed Multiple Myeloma: Final Report of the APEX Study.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2004) 104 (11): 1479.
https://doi.org/10.1182/blood.V104.11.1479.1479
Published: 2004